Logo image of CD

CHINDATA GROUP HOLDINGS-ADR (CD) Stock Fundamental Analysis

NASDAQ:CD - Nasdaq - US16955F1075 - ADR - Currency: USD

8.45  -0.14 (-1.63%)

After market: 8.56 +0.11 (+1.3%)

Fundamental Rating

4

CD gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 82 industry peers in the IT Services industry. CD has a medium profitability rating, but doesn't score so well on its financial health evaluation. CD is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CD was profitable.
In the past year CD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CD reported negative net income in multiple years.
CD had a positive operating cash flow in 4 of the past 5 years.
CD Yearly Net Income VS EBIT VS OCF VS FCFCD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 1B -1B -2B -3B

1.2 Ratios

With a Return On Assets value of 3.12%, CD perfoms like the industry average, outperforming 59.30% of the companies in the same industry.
CD has a Return On Equity (7.36%) which is comparable to the rest of the industry.
With a Return On Invested Capital value of 4.63%, CD perfoms like the industry average, outperforming 55.81% of the companies in the same industry.
CD had an Average Return On Invested Capital over the past 3 years of 2.48%. This is significantly below the industry average of 10.34%.
The 3 year average ROIC (2.48%) for CD is below the current ROIC(4.63%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.12%
ROE 7.36%
ROIC 4.63%
ROA(3y)0.92%
ROA(5y)-1.87%
ROE(3y)2.06%
ROE(5y)-3.93%
ROIC(3y)2.48%
ROIC(5y)N/A
CD Yearly ROA, ROE, ROICCD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 5 -5 -10 -15 -20

1.3 Margins

The Profit Margin of CD (14.84%) is better than 91.86% of its industry peers.
Looking at the Operating Margin, with a value of 27.33%, CD belongs to the top of the industry, outperforming 97.67% of the companies in the same industry.
The Gross Margin of CD (41.17%) is better than 66.28% of its industry peers.
CD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 27.33%
PM (TTM) 14.84%
GM 41.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.47%
GM growth 5YN/A
CD Yearly Profit, Operating, Gross MarginsCD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 -50 -100

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CD is destroying value.
Compared to 1 year ago, CD has more shares outstanding
The debt/assets ratio for CD is higher compared to a year ago.
CD Yearly Shares OutstandingCD Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 100M 200M 300M
CD Yearly Total Debt VS Total AssetsCD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 1.49, we must say that CD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.49, CD is doing worse than 61.63% of the companies in the same industry.
CD has a Debt/Equity ratio of 0.92. This is a neutral value indicating CD is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.92, CD is doing worse than 66.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Altman-Z 1.49
ROIC/WACC0.48
WACC9.67%
CD Yearly LT Debt VS Equity VS FCFCD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 5B 10B

2.3 Liquidity

CD has a Current Ratio of 1.99. This is a normal value and indicates that CD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.99, CD is in the better half of the industry, outperforming 62.79% of the companies in the same industry.
CD has a Quick Ratio of 1.99. This is a normal value and indicates that CD is financially healthy and should not expect problems in meeting its short term obligations.
CD has a better Quick ratio (1.99) than 63.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.99
CD Yearly Current Assets VS Current LiabilitesCD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2B 4B 6B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 116.42% over the past year.
The Revenue has grown by 60.59% in the past year. This is a very strong growth!
The Revenue has been growing by 74.75% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)116.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%121.87%
Revenue 1Y (TTM)60.59%
Revenue growth 3Y74.75%
Revenue growth 5YN/A
Sales Q2Q%49.68%

3.2 Future

The Earnings Per Share is expected to grow by 19.02% on average over the next years. This is quite good.
Based on estimates for the next years, CD will show a very strong growth in Revenue. The Revenue will grow by 22.00% on average per year.
EPS Next Y0.59%
EPS Next 2Y24.1%
EPS Next 3Y27.24%
EPS Next 5Y19.02%
Revenue Next Year40.45%
Revenue Next 2Y31.47%
Revenue Next 3Y28.29%
Revenue Next 5Y22%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CD Yearly Revenue VS EstimatesCD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
CD Yearly EPS VS EstimatesCD Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.61, which indicates a rather expensive current valuation of CD.
Compared to the rest of the industry, the Price/Earnings ratio of CD indicates a somewhat cheap valuation: CD is cheaper than 66.28% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CD to the average of the S&P500 Index (29.62), we can say CD is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 18.21, the valuation of CD can be described as rather expensive.
CD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CD is cheaper than 70.93% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CD to the average of the S&P500 Index (22.70), we can say CD is valued inline with the index average.
Industry RankSector Rank
PE 20.61
Fwd PE 18.21
CD Price Earnings VS Forward Price EarningsCD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CD is valued a bit cheaper than 69.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.91
CD Per share dataCD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CD does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CD's earnings are expected to grow with 27.24% in the coming years.
PEG (NY)34.73
PEG (5Y)N/A
EPS Next 2Y24.1%
EPS Next 3Y27.24%

0

5. Dividend

5.1 Amount

No dividends for CD!.
Industry RankSector Rank
Dividend Yield N/A

CHINDATA GROUP HOLDINGS-ADR

NASDAQ:CD (12/18/2023, 8:00:02 PM)

After market: 8.56 +0.11 (+1.3%)

8.45

-0.14 (-1.63%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-20 2023-11-20/bmo
Earnings (Next)03-13 2024-03-13/amc
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.10B
Analysts82.86
Price Target11.36 (34.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)122.13%
Min EPS beat(2)76.75%
Max EPS beat(2)167.5%
EPS beat(4)4
Avg EPS beat(4)89.95%
Min EPS beat(4)13.15%
Max EPS beat(4)167.5%
EPS beat(8)8
Avg EPS beat(8)192.85%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.39%
Min Revenue beat(2)0.5%
Max Revenue beat(2)10.28%
Revenue beat(4)4
Avg Revenue beat(4)6.1%
Min Revenue beat(4)0.5%
Max Revenue beat(4)10.28%
Revenue beat(8)7
Avg Revenue beat(8)3.7%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-24.12%
EPS NY rev (1m)0%
EPS NY rev (3m)54.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)98760.2%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.05%
Valuation
Industry RankSector Rank
PE 20.61
Fwd PE 18.21
P/S 3.94
P/FCF N/A
P/OCF 10.5
P/B 1.95
P/tB 2.09
EV/EBITDA 10.91
EPS(TTM)0.41
EY4.85%
EPS(NY)0.46
Fwd EY5.49%
FCF(TTM)-1.25
FCFYN/A
OCF(TTM)0.8
OCFY9.52%
SpS2.15
BVpS4.33
TBVpS4.03
PEG (NY)34.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.12%
ROE 7.36%
ROCE 6.8%
ROIC 4.63%
ROICexc 5.92%
ROICexgc 6.19%
OM 27.33%
PM (TTM) 14.84%
GM 41.17%
FCFM N/A
ROA(3y)0.92%
ROA(5y)-1.87%
ROE(3y)2.06%
ROE(5y)-3.93%
ROIC(3y)2.48%
ROIC(5y)N/A
ROICexc(3y)3.27%
ROICexc(5y)N/A
ROICexgc(3y)3.49%
ROICexgc(5y)N/A
ROCE(3y)3.73%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.47%
GM growth 5YN/A
F-Score5
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Debt/EBITDA 3.94
Cap/Depr 480.52%
Cap/Sales 95.88%
Interest Coverage 250
Cash Conversion 79.28%
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.99
Altman-Z 1.49
F-Score5
WACC9.67%
ROIC/WACC0.48
Cap/Depr(3y)606.68%
Cap/Depr(5y)737.01%
Cap/Sales(3y)125.95%
Cap/Sales(5y)327.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%121.87%
EPS Next Y0.59%
EPS Next 2Y24.1%
EPS Next 3Y27.24%
EPS Next 5Y19.02%
Revenue 1Y (TTM)60.59%
Revenue growth 3Y74.75%
Revenue growth 5YN/A
Sales Q2Q%49.68%
Revenue Next Year40.45%
Revenue Next 2Y31.47%
Revenue Next 3Y28.29%
Revenue Next 5Y22%
EBIT growth 1Y57.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year152.3%
EBIT Next 3Y56.96%
EBIT Next 5Y40.16%
FCF growth 1Y-46.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y150.74%
OCF growth 3Y177.53%
OCF growth 5YN/A